Cherrington Julie M
Director at Mirati Therapeutics, Inc.
- Sold, on record
- $687k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jan 18, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mirati Therapeutics, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Mirati Therapeutics, Inc.UnusualMar 2, 2021 2021
Sold 2,000 shares at $201.01 ($402k)
Cherrington Julie M, Director
Sold 57.6% of holdings ($699k position)1,475 shares leftFirst sale on recordFiling
- 2 Form 4 sale Mirati Therapeutics, Inc.UnusualJan 19, 2022 +323 days
Sold 1,475 shares at $116.07 ($171k)
Cherrington Julie M, Director
Sold 36.7% of holdings ($467k position)2,546 shares leftFiling
- 3 Form 4 sale Mirati Therapeutics, Inc.UnusualJan 18, 2023 +364 days
Sold 2,546 shares at $44.66 ($114k)
Cherrington Julie M, Director
Sold 100% of holdings ($114k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | Jan 20, 2023 | Mirati Therapeutics, Inc. | Director | Form 4 sale | 2,546 | $114k | 100.0% | Unusual | SEC |
| Jan 19, 2022 | Jan 20, 2022 | Mirati Therapeutics, Inc. | Director | Form 4 sale | 1,475 | $171k | 36.7% | Unusual | SEC |
| Mar 2, 2021 | Mar 4, 2021 | Mirati Therapeutics, Inc. | Director | Form 4 sale | 2,000 | $402k | 57.6% | Unusual | SEC |